-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Metoprolol is a drug widely used to treat cardiovascular diseases and is beneficial to COVID-19 patients
The most severe form of COVID-19 is severe respiratory failure, which requires intubation and is associated with high mortality
The research was led by Dr.
Madrid-covid is a randomized clinical trial conducted by the FJD Hospital CNIC in close cooperation with cardiology, ICU, pulmonary and biobank services
When introducing the study, Dr.
One of the authors, CNIC Ramón y Cajal researcher Eduardo Oliver, confirmed that intravenous metilol treatment "significantly reduced lung neutrophil infiltration and improved oxygenation
Dr.
Therefore, the researchers proposed that intravenous metoprolol is a "promising intervention that can improve the prognosis of patients with severe COVID-19
Co-first author Agustín Clemente-Moragón added: "The effect of metoprolol on the excessive activation of inflammatory cells in acute respiratory distress syndrome (ARDS) is unique to this receptor blocker
Original search:
DOI 10.
